Merus stock halted today as Genmab buyout closes: what happens to MRUS shares and the $97 cash payout
NEW YORK, December 30, 2025, 11:14 ET — Regular session Merus N.V. shares were halted on Tuesday after Nasdaq said the final merger step in Denmark’s Genmab’s $97-a-share cash acquisition closed before the market open, leaving the stock set for